February 24, 2010
TOKYOResearchers found no benefits of soy products or isoflavone intake with respect to risk of type 2 diabetes in either men or women in a recent Japanese study (J Nutr. 2010;140(3):580-586). A total of 25,872 men and 33,919 women, aged 45 to 75 years, participated in the second survey of the Japan Public Health Center-Based Prospective Study and had no history of diabetes. Soy product and isoflavone intakes were ascertained using a 147-item FFQ. A total of 1,114 new cases of type 2 diabetes were self-reported.
Intakes of soy products and isoflavones were not significantly associated with type 2 diabetes in either men or all women. However, among overweight women (BMI 25 kg/m2), a higher intake of soy products was associated with a lower risk of type 2 diabetes; multivariable-adjusted odds ratios for the lowest through highest quintiles of soy product intake were 1.00 (reference), 0.78 (0.521.18), 0.79 (0.521.20), 0.62 (0.390.99) and 0.89 (0.551.44), respectively, and a similar risk pattern for daidzein and genistein intakes were found. Researchers said the possible protective association of soy and isoflavone intakes among overweight women deserves further investigation.
You May Also Like
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023
More bioavailable hyaluronic acid complex for today’s beauty-from-within consumer – snapshotSep 18, 2023